DAS, Disease Activity Score

Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis
M C Kraan, T J M Smeets, M J van Loon, F C Breedveld, B A C Dijkmans, P P Tak

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1056-1061; DOI: 10.1136/ard.2003.014738
Response criteria for rheumatoid arthritis in clinical practice: how useful are they?
A Gülfe, P Geborek, T Saxne

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1186-1189; DOI: 10.1136/ard.2004.027649
Ectopic lymphoid neogenesis in psoriatic arthritis
Juan D Cañete, Begoña Santiago, Tineke Cantaert, Raimon Sanmartí, Antonio Palacin, Raquel Celis, Eduard Graell, Beatriz Gil-Torregrosa, Dominique Baeten, José L Pablos

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 720-726; DOI: 10.1136/ard.2006.062042
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
Gerd R Burmester, Xavier Mariette, Carlomaurizio Montecucco, Indalecio Monteagudo-Sáez, Michel Malaise, Athanasios G Tzioufas, Johannes W J Bijlsma, Kristina Unnebrink, Sonja Kary, Hartmut Kupper

Annals of the Rheumatic Diseases Jun 2007, 66 (6) 732-739; DOI: 10.1136/ard.2006.066761
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)
K Forslind, M Ahlmén, K Eberhardt, I Hafström, B Svensson

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1090-1095; DOI: 10.1136/ard.2003.014233
Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis
J Fransen, R F J M Laan, M A F J van der Laar, T W J Huizinga, P L C M van Riel

Annals of the Rheumatic Diseases Oct 2004, 63 (10) 1222-1226; DOI: 10.1136/ard.2003.018861
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis
S L Hider, A Silman, D Bunn, S Manning, D Symmons, M Lunt

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1449-1455; DOI: 10.1136/ard.2005.049775
Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results
D van der Heijde, L Klareskog, M Boers, R Landewé, C Codreanu, H D Bolosiu, R Pedersen, S Fatenejad

Annals of the Rheumatic Diseases Nov 2005, 64 (11) 1582-1587; DOI: 10.1136/ard.2004.034371
Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study
J van Aken, H van Dongen, S le Cessie, C F Allaart, F C Breedveld, T W J Huizinga

Annals of the Rheumatic Diseases Jan 2006, 65 (1) 20-25; DOI: 10.1136/ard.2005.038471
Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trials
T Pincus, T Sokka, C P Chung, G Cawkwell

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 878-883; DOI: 10.1136/ard.2005.044131

Main menu

DAS, Disease Activity Score

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

DAS, Disease Activity Score

Pages